Drug Industry Offers Tepid Pushback to Kennedy’s FDA Job Cuts - Barron's
1. Drug stocks fell due to job cuts at FDA and leadership disputes. 2. Pfizer shares dropped 3.2% amid concerns over FDA's operational capacity. 3. PhRMA expressed concerns about FDA's ability to approve new medicines. 4. Trump's administration may implement significant price cuts to drugs. 5. Vaccine skepticism from Kennedy influences drug industry dynamics.